Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia.

Saved in:
Bibliographic Details
Title: Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia.
Authors: Al-Abdulkarim H; National Guard Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Doctoral School of Applied Informatics and Applied Mathematics, Óbuda University, Budapest, Hungary., Sharma Y; IQVIA, London, UK., Attar SM; Rheumatology & Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia., Husain W; Heraa Hospital, Makkah, Saudi Arabia., Al-Homood I; Internal Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia., Al Omari B; Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Mohamed O; Real-World Evidence (RWE), IQVIA AG, Dubai, United Arab Emirates., Alsaqa'aby M; Real-World Evidence (RWE), IQVIA Solutions, Riyadh, Saudi Arabia., Jaheen AM; Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi Arabia., Anwar A; Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi Arabia., Hamad TM; Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi Arabia., Alzahrani Z; Department of Surgery, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Source: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 134-144. Date of Electronic Publication: 2024 Jan 01.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1941-837X
DOI:10.1080/13696998.2023.2299176